Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b

Carcinogenesis

Volumn 31, Issue 7, 2010, Pages 1194-1201

  Kwon, Osong ^a   Jeong, Sook Jung ^a   Kim, Sun Ok ^a   He, Long ^a   Lee, Hee Gu ^a   Jang, Kyung Lib ^b   Osada, Hiroyuki ^c   Jung, Mira ^d   Kim, Bo Yeon ^a   Ahn, Jong Seog ^a  

^a Korea Research Institute Yangcheong Ri   (South Korea)

^b Pusan National University   (South Korea)

^c RIKEN   (Japan)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; DNA METHYLTRANSFERASE 3B; K RAS PROTEIN; SMALL INTERFERING RNA; UVOMORULIN;

ARTICLE; CANCER CELL; CELL AGGREGATION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AZACITIDINE; CADHERINS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENES, RAS; HUMANS; MALE; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS;

EID: 77954358329     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq071     Document Type: Article

References (46)

1. Ehrhardt,A. et al. (2002) Ras and relatives-job sharing and networking keep an old family together. Exp. Hematol., 30, 1089-1106.
2. Hancock,J.F. (2003) Ras proteins: different signals from different locations. Nat. Rev. Mol. Cell Biol., 4, 373-384.
3. Malumbres,M. et al. (2003) RAS oncogenes: the first 30 years. Nat. Rev. Cancer, 3, 459-465.
4. Egger,G. et al. (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature, 429, 457-463.
5. Heard,E. et al. (1997) X-chromosome inactivation in mammals. Annu. Rev. Genet., 31, 571-610.
6. Li,E. et al. (1993) Role for DNA methylation in genomic imprinting. Nature, 366, 362-365.
7. Li,E. et al. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69, 915-926.
8. Ng,H.H. et al. (1999) DNA methylation and chromatin modification. Curr. Opin. Genet. Dev., 9, 158-163.
9. Leonhardt,H. et al. (1992) A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell, 71, 865-873.
10. Okano,M. et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247-257.
11. Chen,W. et al. (2004) Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell, 6, 387-398.
12. Costello,J.F. et al. (2000) Aberrant CpG-island methylation has nonrandom and tumour-type-specific patterns. Nat. Genet., 24, 132-138.
13. Gronbaek,K. et al. (2007) Epigenetic changes in cancer. APMIS, 115, 1039-1059.
14. Hoffmann,M.J. et al. (2005) Causes and consequences of DNA hypomethylation in human cancer. Biochem. Cell Biol., 83, 296-321.
15. Holst,C.R. et al. (2003) Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia. Cancer Res., 63, 1596-1601.
16. Toyota,M. et al. (1999) CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA, 96, 8681-8686.
17. Clark,S.J. (2007) Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis. Hum Mol Genet, 16. Spec No 1, R88-R95.
18. Nagafuchi,A. et al. (1987) Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA. Nature, 329, 341-343.
19. Herman,J.G. et al. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821-9826.
20. Takeichi,M. (1988) The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development, 102, 639-655.
21. Melki,J.R. et al. (2000) Hypermethylation of E-cadherin in leukemia. Blood, 95, 3208-3213.
22. Berx,G. et al. (1996) E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene, 13, 1919-1925.
23. Tamura,G. et al. (2000) E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J. Natl Cancer Inst., 92, 569-573.
24. Matsui,T. et al. (2002) K-Ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J., 21, 1021-1030.
25. Kim,B.Y. et al. (2002) Constitutive activation of NF-kappaB in Ki-ras-transformed prostate epithelial cells. Oncogene, 21, 4490-4497.
26. Kwon,O. et al. (2008) Complex formation of p65/RelA with nuclear Akt1 for enhanced transcriptional activation of NF-kappaB. Biochem. Biophys. Res. Commun., 365, 771-776.
27. Parda,D.S. et al. (1993) Neoplastic transformation of a human prostate epithelial cell line by the v-Ki-ras oncogene. Prostate, 23, 91-98.
28. Kwon,O. et al. (2006) NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. Carcinogenesis, 27, 2258-2268.
29. Lee,J.O. et al. (2005) Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1. Oncogene, 24, 6617-6625.
30. Tsai,C.N. et al. (2002) The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc. Natl Acad. Sci. USA, 99, 10084-10089.
31. Kawanishi,J. et al. (1995) Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC39. Mol. Cell. Biol., 15, 1175-1181.
32. Barrallo-Gimeno,A. et al. (2005) The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development, 132, 3151-3161.
33. Bolos,V. et al. (2003) The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J. Cell Sci., 116, 499-511.
34. Nieto,M.A. (2002) The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell Biol., 3, 155-166.
35. Tsai,C.L. et al. (2006) Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. Cancer Res., 66, 11668-11676.
36. Liu,Y.N. et al. (2005) Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene, 24, 8277-8290.
37. Xiong,Y. et al. (2005) Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. Cancer Res., 65, 2684-2689.
38. Takeichi,M. (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451-1455.
39. Ghoshal,K. et al. (2005) 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal. Mol. Cell. Biol., 25, 4727-4741.
40. Deng,C. et al. (2001) Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum., 44, 397-407.
41. Ramchandani,S. et al. (1999) DNA methylation is a reversible biological signal. Proc. Natl Acad. Sci. USA, 96, 6107-6112.
42. Detich,N. et al. (2001) A conserved 3'-untranslated element mediates growth regulation of DNA methyltransferase 1 and inhibits its transforming activity. J. Biol. Chem., 276, 24881-24890.
43. Rountree,M.R. et al. (2001) DNA methylation, chromatin inheritance, and cancer. Oncogene, 20, 3156-3165.
44. Hellebrekers,D.M. et al. (2007) Identification of epigenetically silenced genes in tumor endothelial cells. Cancer Res., 67, 4138-4148.
45. Eads,C.A. et al. (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res., 59, 2302-2306.
46. Kimura,F. et al. (2003) Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int. J. Cancer, 104, 568-578.